Chronic Rhinosinusitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 65 years old (male or female)
- You have been diagnosed with chronic sinusitis with nasal polyps, confirmed by a camera examination of the nose, CT scan, or MRI, following current international guidelines
- Your blood clotting tests (including clotting time and platelet count) are within the normal range
- You do not have serious heart or lung problems that would make it unsafe for you to have general anesthesia and surgery
- If you are a woman who could become pregnant, you must be willing to use reliable contraception during the study and for 4 weeks after treatment ends
- You are willing to follow the study instructions, take part voluntarily, and sign a consent form
Who may not be able to join:
- You have other nose or sinus conditions beyond chronic sinusitis, such as nasal tumors, fungal sinus infections, or nasal deformities caused by injury
- You have a blood clotting disorder, a weakened immune system, take blood-thinning or anti-clotting medications regularly, or are currently on your period at the time of your visit
- You have taken steroid tablets (such as prednisone) by mouth within the past month
- You have previously had nasal endoscopic surgery or radiation treatment to the nose area
- You are pregnant or breastfeeding, or you have serious uncontrolled health conditions such as high blood pressure, diabetes, or liver or kidney problems
- Your medical records are incomplete or you are unlikely to attend follow-up appointments after treatment
- You have difficulty following treatment plans or instructions
- The trial team has any other concerns about your suitability for the study (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13256875886
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The agreement between the results of device-based typing diagnosis and the pathological gold standard
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.